Stephen Basil Thomas

CLYM

Stephen Basil Thomas serves as director at Climb Bio, Inc. (CLYM). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

4 trades

$2.78M

Net Position

Net Seller

$2.78M

Companies Traded

CLYM

Active Period

Feb 2026 – Sep 2026

4 total trades

Most Recent

Sell CLYM

Sep 17, 2026 · $1.37M

Stephen Basil Thomas's Insider Trading at Climb Bio, Inc. (CLYM)

Buys

0 · $0.00

Sells

4 · $2.78M

Total Shares Bought

Total Shares Sold

350,000

CLYM Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Sep 17, 2026	Sell	100,000	$13.67	$1.37M	467,969
Feb 27, 2026	Sell	50,000	$7.01	$350.3K	170,970
Feb 17, 2026	Sell	100,000	$5.29	$529.1K	214,657
Feb 12, 2026	Sell	100,000	$5.29	$529.1K	0

Related Insiders

Aoife Brennan

director, officer: President and CEO

CLYMSell · Jun 30, 2026

RA CAPITAL MANAGEMENT, L.P.

director, 10 percent owner:

CLYMBuy · Jan 7, 2026

Explore More Insider Trading Data

CLYM Insider Trading Activity

View all insider trades at Climb Bio, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity